Diagnos
(TSXV) ADK
Diagnos Financials at a Glance
Market Cap
CA$32.51MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
CA$65.48K
Net Income (TTM)
-CA$4.56M
EPS (TTM)
-CA$0.04
P/E Ratio
-6.52
Dividend
CA$0.00
Beta (Volatility)
-0.05 (Low)
Dividend
CA$0.00
Beta (Volatility)
-0.05 (Low)
Price
CA$0.27
Volume
86,769
Open
CA$0.27
Price
CA$0.27
Volume
86,769
Open
CA$0.27
Previous Close
CA$0.27
Daily Range
CA$0.26 - CA$0.27
52-Week Range
CA$0.18 - CA$0.42
Estimated Earnings Date
Aug 24, 2026
Dividend
CA$0.00
Beta (Volatility)
-0.05 (Low)
Price
CA$0.27
Volume
86,769
Open
CA$0.27
Previous Close
CA$0.27
Daily Range
CA$0.26 - CA$0.27
52-Week Range
CA$0.18 - CA$0.42
Estimated Earnings Date
Aug 24, 2026
ADK News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Diagnos
Industry
Health Care Technology
Sector
Health CareCEO
André M. Larente
Website
www.diagnos.comHeadquarters
Brossard, QC J4Z 1A7, CA
ADK Financials
Key Financial Metrics (TTM)
Gross Margin
-182.42%
Operating Margin
-6510.52%
Net Income Margin
-6956.84%
Return on Equity
11659.44%
Return on Capital
-204.11%
Return on Assets
-190.55%
Earnings Yield
-15.34%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
CA$32.51MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
120.41M
Volume
86.77K
Avg. Volume
205.89K
Financials (TTM)
Gross Profit
-CA$119.45K
Operating Income
-CA$4.26M
EBITDA
-CA$4.09M
Operating Cash Flow
-CA$3.86M
Capital Expenditure
-CA$11.07K
Free Cash Flow
-CA$3.87M
Cash & ST Invst.
CA$1.93M
Total Debt
CA$1.40M
Diagnos Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CA$15.71K
-14.6%
Gross Profit
CA$1.02M
+449.8%
Gross Margin
64.63%
N/A
Market Cap
CA$32.51MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
CA$2.03M
N/A
Employees
16
N/A
Net Income
-CA$1.18M
+11.4%
EBITDA
-CA$1.15M
+0.2%
Quarterly Fundamentals
Total Cash
CA$1.93M
-40.4%
Total Debt
CA$1.40M
-54.4%
Accounts Receivable
CA$194.86K
+27.8%
Inventory
CA$0.00
N/A
Long Term Debt
CA$225.71K
-21.1%
Short Term Debt
CA$1.18M
-57.8%
Return on Assets
-1.91%
N/A
Return on Invested Capital
-4.67%
N/A
Free Cash Flow
-CA$1.31M
-5.7%
Operating Cash Flow
-CA$1.31M
-5.7%